Among his notable contributions is the development of the NAGI Stent, a widely adopted device for the drainage of pancreatic pseudocysts
Bidding window open till May 15; study to map costs and bottlenecks across pharma supply chains
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy
API-first, DPI-driven DDRS platform aims to modernize drug and medical device regulation in India
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
CDSCO-cleared BSM-5700 series targets ICU, NICU, ER, OR and digital health integration under ABDM
Move amid evidence of widespread reporting gaps
Paves the way for next-gen ultra-precise gas sensing
Subscribe To Our Newsletter & Stay Updated